Yoon, Wan-Soo
Chang, Jong Hee
Kim, Jeong Hoon
Kim, Yu Jung
Jung, Tae-Young
Yoo, Heon
Kim, Se-Hyuk
Ko, Young-Cho
Nam, Do-Hyun
Kim, Tae Min
Kim, Se Hoon
Park, Sung-Hae
Lee, Youn Soo
Yim, Hyeon Woo
Hong, Yong-Kil
Yang, Seung Ho
Clinical trials referenced in this document:
Documents that mention this clinical trial
Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)
https://doi.org/10.1007/s12672-023-00678-3
Article History
Received: 25 January 2023
Accepted: 28 April 2023
First Online: 6 June 2023
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of The Catholic University of Korea (March 22, 2017/No. VC15MIMS0233). Written informed consent was obtained from the patients.
: Not required.
: The authors have no relevant financial or nonfinancial interests to disclose.